CAS: 1446502-11-9 - 2-Methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-2-propanol
Formula:C19H17F6N7O
InChI:InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)
InChI key:InChIKey=DYLUUSLLRIQKOE-UHFFFAOYSA-N
SMILES:FC(F)(F)C1=NC(=CC=C1)C=2N=C(N=C(N2)NCC(O)(C)C)NC=3C=CN=C(C3)C(F)(F)F
Ref: 4Z-K-031042
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
Enasidenib
CAS:1446502-11-9
Enasidenib (AG-221) is an orally available inhibitor of specific mutant forms of the mitochondrial enzyme …
Formula:
C19H17F6N7O
Purity:
100%
Color and Shape:
Solid
Molecular weight:
473.38
Ref: TM-T2346
5mg | 51.00 € | |
10mg | 74.00 € | |
25mg | 91.00 € | |
50mg | 114.00 € | |
100mg | 147.00 € | |
200mg | 204.00 € | |
500mg | 344.00 € | |
1ml*10 (DMSO) | 51.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Enasidenib
Controlled ProductCAS:1446502-11-9
Formula:
C19H17F6N7O
Color and Shape:
White to Off-White Solid
Molecular weight:
473.37
Ref: TR-E555360
5mg | 164.00 € | |
10mg | 224.00 € | |
50mg | 744.00 € |
Estimated delivery in United States, on Monday 13 May 2024
AG 221
CAS:1446502-11-9
Inhibitor of isocitrate dehydrogenase 2
Formula:
C19H17F6N7O
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
473.38 g/mol
Ref: 3D-FA145490
2mg | 103.00 € | |
5mg | 141.00 € | |
10mg | 191.00 € | |
25mg | 318.00 € | |
50mg | 418.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-
CAS:1446502-11-9
Formula:
C19H17F6N7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
473.3750
Ref: AN-AG001JXC
1g | Discontinued | |
100mg | Discontinued | |
250mg | Discontinued |